Zoledronic and Metastases to lung - a phase IV clinical study of FDA data
Summary:
Metastases to lung is reported as a side effect among people who take Zoledronic (zoledronic acid), especially for people who are female, 60+ old, have been taking the drug for 1 - 2 years also take Palbociclib, and have Breast cancer.
The phase IV clinical study analyzes which people have Metastases to lung when taking Zoledronic. It is created by eHealthMe based on reports of 29,760 people who have side effects when taking Zoledronic from the FDA, and is updated regularly.
What is Zoledronic?
Zoledronic has active ingredients of zoledronic acid. eHealthMe is studying from 29,812 Zoledronic users. Check the latest studies of Zoledronic.
What is Metastases to lung?
Metastases to lung (cancer spreads to lung) is found to be associated with 835 drugs and 849 conditions by eHealthMe. Check the latest studies of Metastases to lung.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
29,760 people reported to have side effects when taking Zoledronic.
Among them, 276 people (0.93%) have Metastases to lung.
Among these 276 people:
How long have people been on Zoledronic when they have Metastases to lung? *
What is the gender of people who have Metastases to lung when taking Zoledronic? *
What is the age of people who have Metastases to lung when taking Zoledronic? *
What are other drugs people take besides Zoledronic? *
What are other side effects people have besides Metastases to lung? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Zoledronic and have Metastases to lung?
- Check whether Metastases to lung is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Zoledronic:
- Zoledronic (29,812 reports)
Metastases to lung treatments and more:
- Metastases to lung (19,400 reports)
How severe was Metastases to lung and when was it recovered:
Expand to all the drugs that have ingredients of zoledronic acid:
- Metastases to lung and drugs with ingredients of zoledronic acid (1,334 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Zoledronic:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Metastases to lung:
- Metastases to lung (835 drugs)
Browse all the conditions that are associated with Metastases to lung:
- Metastases to lung (849 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on zoledronic acid (the active ingredients of Zoledronic) and Zoledronic (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Iron Deficiency and drugs of ingredients of tolterodine tartrate - now
- Could Warfarin Sodium cause Myocarditis? - a second ago
- Could Tylenol cause Mumps? - 2 seconds ago
- Drug interactions of Prochlorperazine Maleate and Lovenox - 3 seconds ago
- Bone Pain and drugs of ingredients of enasidenib mesylate - 3 seconds ago
- Glaucoma Aggravated and drugs of ingredients of estrogens, conjugated - 6 seconds ago
- Thrombosed Varicose Vein and drugs of ingredients of pregabalin - 9 seconds ago
- Haematocrit Decreased and drugs of ingredients of lapatinib ditosylate - 11 seconds ago
- Rash Pustular and drugs of ingredients of lorazepam - 11 seconds ago
- Fatigue and drugs of ingredients of micafungin sodium - 11 seconds ago